Treatment of ARDS samples with doxycycline, an antimicrobial agent with MMP inhibitory properties [12] resulted in a 50% reduction in MMP-9 activity (Figure 3B, p = 0.04). Here, MMP9 is linked to acute respiratory distress syndrome.